Nauru vs Tuvalu: The number of people with susceptibility test result for rifampicin
Nauru
14
in 2021
Tuvalu
19
in 2021
Nauru rank
136th
Tuvalu rank
133rd
The number of people with susceptibility test result for rifampicin over time
- Nauru
- Tuvalu
How they compare
Tuvalu currently reports 19 against 14 in Nauru, a difference of 5.
That makes Tuvalu's figure about 1.4 times Nauru's.
Across all 5 years both countries report, Tuvalu has been ahead every year.
Nauru ranks 136th and Tuvalu ranks 133rd of 155 countries.
Tuvalu has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Nauru | Tuvalu | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0 | 14 | 14 | Tuvalu |
| 2020s | 7 | 17 | 10 | Tuvalu |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Nauru or Tuvalu?
- Tuvalu, at 19 against 14 in Nauru as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Nauru and Tuvalu?
- 5, with Tuvalu ahead.
- How many years of comparable data are there for Nauru and Tuvalu?
- 5 years are reported by both, from 2017 to 2021.
- How do Nauru and Tuvalu rank globally for the number of people with susceptibility test result for rifampicin?
- Nauru ranks 136th and Tuvalu ranks 133rd of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.